TABLE OF CONTENTS
Volume 26, Issue 9 (26 February 2007)
Guest Editors
Top of pageIntroduction
Cancer: biology and therapeutics – A tribute to George Vande Woude
N S Duesbery and B T Teh
Oncogene 26: 1258-1259; doi:10.1038/sj.onc.1210257
Reviews
A not so brief history of the Oncogene Meeting and its Cartoons
T Hunter and J Simon
Oncogene 26: 1260-1267; doi:10.1038/sj.onc.1210262
Oncogenic re-wiring of cellular signaling pathways
T Pawson and N Warner
Oncogene 26: 1268-1275; doi:10.1038/sj.onc.1210255
From Tpr-Met to Met, tumorigenesis and tubes
P Peschard and M Park
Oncogene 26: 1276-1285; doi:10.1038/sj.onc.1210201
New insight into metaphase arrest by cytostatic factor: from establishment to release
J Liu, B Grimison and J L Maller
Oncogene 26: 1286-1289; doi:10.1038/sj.onc.1210203
MKK signaling and vascularization
P E Depeille, Y Ding, J L Bromberg-White and N S Duesbery
Oncogene 26: 1290-1296; doi:10.1038/sj.onc.1210198
Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions
E Klein, L L Kis and G Klein
Oncogene 26: 1297-1305; doi:10.1038/sj.onc.1210240
Coping with stress: multiple ways to activate p53
H F Horn and K H Vousden
Oncogene 26: 1306-1316; doi:10.1038/sj.onc.1210263
A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans
G L Bond and A J Levine
Oncogene 26: 1317-1323; doi:10.1038/sj.onc.1210199
The Bcl-2 apoptotic switch in cancer development and therapy
J M Adams and S Cory
Oncogene 26: 1324-1337; doi:10.1038/sj.onc.1210220
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer
R L Dillon, D E White and W J Muller
Oncogene 26: 1338-1345; doi:10.1038/sj.onc.1210202
Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling
K A Furge, M H Tan, K Dykema, E Kort, W Stadler, X Yao, M Zhou and B T Teh
Oncogene 26: 1346-1350; doi:10.1038/sj.onc.1210256
Discovery and development of SAHA as an anticancer agent
P A Marks
Oncogene 26: 1351-1356; doi:10.1038/sj.onc.1210204
